Chemistry:Sunobinop
From HandWiki
Short description: Chemical compound
Clinical data | |
---|---|
Other names | IMB-115 |
Drug class | Nociceptin receptor agonist |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C26H33N3O3 |
Molar mass | 435.568 g·mol−1 |
3D model (JSmol) | |
| |
|
Sunobinop (developmental code name IMB-115) is a nociceptin receptor partial agonist and opioid receptor pan-antagonist.[1] As of March 2022, it is under investigation for the treatment of insomnia, fibromyalgia, and overactive bladder.[1][2]
See also
References
- ↑ 1.0 1.1 "Sunobinop - Shionogi/Imbrium Therapeutics". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800035863.
- ↑ Harris SC, Kapil RP, Kyle DJ, Whiteside G, "Treatment and prevention of sleep disorders", WO patent application 2018020418, published 2018-02-01, assigned to Purdue Pharma L.P.
Original source: https://en.wikipedia.org/wiki/Sunobinop.
Read more |